Invitation to attend XVIVO Perfusion’s conference call regarding presentation of the interim report for the period January – March, 2014. The presentation will be held in English. Time: Wednesday, April 23, 2014 at 2.00 p.m. CET Registration can preferably be done in advance under the following link: https://engage.vevent.com/rt/xvivoperfusion~1319928 or shortly before time of the conference starts on: Sweden dial in number: +46 (0)8-503 364 34 International dial in number: +44 (0) 1452 555566 Conference name: XVIVO Perfusion, conference ID: 1319928 Participants from XVIVO Perfusion: Magnus Nilsson, CEO Christoffer Rosenblad, CFO The press release for XVIVO Perfusion’s interim report for the period January – March, 2014 will be released before the conference call April 23, 2014. Before the conference call, slides will be available at the company web page, www.xvivoperfusion.com/corporate/. April 14, 2014 Gothenburg XVIVO Perfusion AB (publ) For further information please contact: Christoffer Rosenblad, CFO, +46 31 788 21 59, christoffer.rosenblad@xvivoperfusion.com For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails. ________________________________________________________________________________ _ _____________________________________ XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation. The company is headquartered in Gothenburg, Sweden, and has one office in the USA. The XVIVO share is listed on NASDAQ OMX First North and has the ticker symbol XVIVO. More information can be found on the website www.xvivoperfusion.com. The Certified Adviser is Redeye, www.redeye.se. ________________________________________________________________________________ _ _____________________________________ XVIVO Perfusion AB (publ), Box 53015, SE-400 14 Göteborg. Corporate identity number 556561-0424. Tel: 46 31 788 21 50. Fax: 46 31 788 21 69. E-mail: info@xvivoperfusion.com. Website: www.xvivoperfusion.com
Conference call interim report
| Source: Xvivo Perfusion AB